We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
International Flavors (IFF) Q4 Earnings Preview: What You Should Know Beyond the Headline Estimates
Read MoreHide Full Article
Analysts on Wall Street project that International Flavors (IFF - Free Report) will announce quarterly earnings of $0.85 per share in its forthcoming report, representing a decline of 12.4% year over year. Revenues are projected to reach $2.51 billion, declining 9.4% from the same quarter last year.
The current level reflects an upward revision of 1.7% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.
Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.
While investors typically rely on consensus earnings and revenue estimates to gauge how the business may have fared during the quarter, examining analysts' projections for some of the company's key metrics often helps gain a deeper insight.
Bearing this in mind, let's now explore the average estimates of specific International Flavors metrics that are commonly monitored and projected by Wall Street analysts.
The collective assessment of analysts points to an estimated 'Net Sales- Health & Biosciences' of $554.97 million. The estimate suggests a change of +0.4% year over year.
The consensus among analysts is that 'Net sales- Scent' will reach $589.73 million. The estimate indicates a change of +1.9% from the prior-year quarter.
Analysts expect 'Adjusted Operating EBITDA- Scent' to come in at $111.73 million. The estimate is in contrast to the year-ago figure of $97.00 million.
The combined assessment of analysts suggests that 'Adjusted Operating EBITDA- Health & Biosciences' will likely reach $132.53 million. Compared to the present estimate, the company reported $157.00 million in the same quarter last year.
International Flavors shares have witnessed a change of +7.1% in the past month, in contrast to the Zacks S&P 500 composite's -1.5% move. With a Zacks Rank #3 (Hold), IFF is expected closely follow the overall market performance in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
International Flavors (IFF) Q4 Earnings Preview: What You Should Know Beyond the Headline Estimates
Analysts on Wall Street project that International Flavors (IFF - Free Report) will announce quarterly earnings of $0.85 per share in its forthcoming report, representing a decline of 12.4% year over year. Revenues are projected to reach $2.51 billion, declining 9.4% from the same quarter last year.
The current level reflects an upward revision of 1.7% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.
Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.
While investors typically rely on consensus earnings and revenue estimates to gauge how the business may have fared during the quarter, examining analysts' projections for some of the company's key metrics often helps gain a deeper insight.
Bearing this in mind, let's now explore the average estimates of specific International Flavors metrics that are commonly monitored and projected by Wall Street analysts.
The collective assessment of analysts points to an estimated 'Net Sales- Health & Biosciences' of $554.97 million. The estimate suggests a change of +0.4% year over year.
The consensus among analysts is that 'Net sales- Scent' will reach $589.73 million. The estimate indicates a change of +1.9% from the prior-year quarter.
Analysts expect 'Adjusted Operating EBITDA- Scent' to come in at $111.73 million. The estimate is in contrast to the year-ago figure of $97.00 million.
The combined assessment of analysts suggests that 'Adjusted Operating EBITDA- Health & Biosciences' will likely reach $132.53 million. Compared to the present estimate, the company reported $157.00 million in the same quarter last year.
View all Key Company Metrics for International Flavors here>>>International Flavors shares have witnessed a change of +7.1% in the past month, in contrast to the Zacks S&P 500 composite's -1.5% move. With a Zacks Rank #3 (Hold), IFF is expected closely follow the overall market performance in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .